NZ601890A - Treatment or prevention of infection - Google Patents
Treatment or prevention of infectionInfo
- Publication number
- NZ601890A NZ601890A NZ601890A NZ60189011A NZ601890A NZ 601890 A NZ601890 A NZ 601890A NZ 601890 A NZ601890 A NZ 601890A NZ 60189011 A NZ60189011 A NZ 60189011A NZ 601890 A NZ601890 A NZ 601890A
- Authority
- NZ
- New Zealand
- Prior art keywords
- subject
- oral tissue
- infection
- prevention
- treatment
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 241000605862 Porphyromonas gingivalis Species 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 210000004195 gingiva Anatomy 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0208—Specific bacteria not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2010900846A AU2010900846A0 (en) | 2010-02-26 | Treatment or prevention of infection | |
| PCT/AU2011/000206 WO2011103633A1 (en) | 2010-02-26 | 2011-02-25 | Treatment or prevention of infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ601890A true NZ601890A (en) | 2015-01-30 |
Family
ID=44506081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ601890A NZ601890A (en) | 2010-02-26 | 2011-02-25 | Treatment or prevention of infection |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9125853B2 (enExample) |
| EP (2) | EP3260135A1 (enExample) |
| JP (1) | JP5977677B2 (enExample) |
| KR (2) | KR20170109685A (enExample) |
| CN (2) | CN102883744A (enExample) |
| AU (1) | AU2011220335B2 (enExample) |
| BR (1) | BR112012021383A2 (enExample) |
| CA (1) | CA2790219C (enExample) |
| HK (1) | HK1248535A1 (enExample) |
| MX (1) | MX342832B (enExample) |
| MY (1) | MY162557A (enExample) |
| NZ (1) | NZ601890A (enExample) |
| RU (1) | RU2617399C2 (enExample) |
| SG (2) | SG183376A1 (enExample) |
| TW (1) | TWI583392B (enExample) |
| WO (1) | WO2011103633A1 (enExample) |
| ZA (1) | ZA201206204B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0811530B1 (pt) | 2007-05-14 | 2019-01-02 | Research Foundation Of State Univ Of New York | composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície |
| EP2328914B1 (en) * | 2008-08-29 | 2017-05-10 | Oral Health Australia Pty Ltd | Prevention, treatment and diagnosis of p.gingivalis infection |
| WO2010144968A1 (en) * | 2009-06-19 | 2010-12-23 | Oral Health Australia Pty Ltd | Casein derived protease inhibitory peptides |
| WO2016061264A1 (en) * | 2014-10-14 | 2016-04-21 | The Forsyth Institute | Conjugates for delivery to mitochondria |
| KR101587113B1 (ko) * | 2014-10-29 | 2016-01-20 | 경북대학교 산학협력단 | 치주염 유발 장알균(Enterococcus faecalis)을 특이적으로 사멸시키는 신규한 박테리오파지 |
| EP3389704B1 (en) * | 2015-12-15 | 2022-01-26 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Vaccination against diabetes, obesity and complications thereof |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| CA3133097A1 (en) | 2019-03-13 | 2020-09-17 | The University Of Melbourne | Compositions and methods for promoting mineralization |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5210035A (en) | 1980-05-19 | 1993-05-11 | Board Of Trustees Of Leland Stanford Jr. University | Non-reventing live vaccines |
| US4735801A (en) | 1982-09-07 | 1988-04-05 | Board Of Trustees Of Leland Stanford Jr. University | Novel non-reverting salmonella live vaccines |
| US4837151A (en) | 1980-05-19 | 1989-06-06 | The Board Of Trustees Of The Leland Stanford Junior University, Stanford University | Live vaccines comprising two mutations and foreign antigen |
| US4603112A (en) | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
| CA2128711C (en) | 1992-01-30 | 2005-01-11 | Terence K. Brunck | Trypsin inhibitors |
| JPH0797395A (ja) | 1993-09-28 | 1995-04-11 | Kyowa Medex Co Ltd | ポルフイロモナス・ジンジバリス線毛蛋白質の配列を含有するペプチド類及びその用途 |
| AUPN627595A0 (en) | 1995-10-30 | 1995-11-23 | University Of Melbourne, The | Diagnostics and treatments of periodontal disease |
| AUPO652897A0 (en) | 1997-04-30 | 1997-05-29 | University Of Melbourne, The | Synthetic peptide constructs for the diagnosis and treatment of periodontitis |
| AUPP893999A0 (en) | 1999-03-01 | 1999-03-25 | Csl Limited | Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis |
| AUPQ485999A0 (en) | 1999-12-24 | 2000-02-03 | Csl Limited | P. gingivalis antigenic composition |
| US8283135B2 (en) * | 2000-06-30 | 2012-10-09 | The Procter & Gamble Company | Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| GB0114185D0 (en) | 2001-06-12 | 2001-08-01 | Protherics Molecular Design Lt | Compounds |
| GB2370838A (en) | 2001-01-06 | 2002-07-10 | Benedikt Timmerman | Immunogenic complex |
| JP2005537245A (ja) | 2002-06-26 | 2005-12-08 | エントレメッド インコーポレイテッド | タンパク質活性化レセプターのアンタゴニストを含む組成物および方法 |
| US20070036734A1 (en) | 2003-03-17 | 2007-02-15 | Kirin Beer Kabushiki Kaisha | Therapeutic agent for periodontal disease |
| US20050070543A1 (en) * | 2003-07-11 | 2005-03-31 | Pharmacia Corporation | Compositions of a chromene or phenyl acetic acid cyclooxygenase-2 selective inhibitor and an ACE inhibitor for the treatment of central nervous system damage |
| ATE495189T1 (de) * | 2003-08-15 | 2011-01-15 | Univ Florida | Die identifikation von polynukleotiden von porphyromonas gingivalis-virulenz zur diagnose, behandlung und beobachtung von periodontalerkrankungen |
| GB0411150D0 (en) * | 2004-05-19 | 2004-06-23 | Queen Mary & Westfield College | Vaccine |
| CA2576971A1 (en) | 2004-08-20 | 2006-03-02 | Entremed, Inc. | Compositions and methods comprising proteinase activated receptor antagonists |
| NZ554331A (en) | 2004-09-23 | 2009-04-30 | Univ Melbourne | Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection |
| US7888482B2 (en) | 2006-02-10 | 2011-02-15 | Amgen Inc. | Antibodies that bind PAR-2 |
| CA2652957A1 (en) | 2006-06-27 | 2008-01-03 | Oral Health Australia Pty Ltd. | Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease |
| EP2638905B1 (en) | 2007-07-12 | 2019-01-16 | Oral Health Australia Pty Ltd | Biofilm treatment |
| RU2366378C1 (ru) * | 2008-04-07 | 2009-09-10 | Сергей Владимирович Сирак | Способ костной пластики при непосредственной дентальной имплантации |
| MX2012001495A (es) * | 2009-08-02 | 2012-08-03 | Sanofi Pasteur Ltd | Polipeptidos de porphyromonas gingivalis. |
-
2011
- 2011-02-23 MY MYPI2012003796A patent/MY162557A/en unknown
- 2011-02-25 AU AU2011220335A patent/AU2011220335B2/en active Active
- 2011-02-25 JP JP2012554168A patent/JP5977677B2/ja active Active
- 2011-02-25 KR KR1020177026249A patent/KR20170109685A/ko not_active Ceased
- 2011-02-25 US US13/580,090 patent/US9125853B2/en active Active
- 2011-02-25 TW TW100106637A patent/TWI583392B/zh not_active IP Right Cessation
- 2011-02-25 CN CN2011800183736A patent/CN102883744A/zh active Pending
- 2011-02-25 BR BR112012021383A patent/BR112012021383A2/pt not_active Application Discontinuation
- 2011-02-25 CA CA2790219A patent/CA2790219C/en active Active
- 2011-02-25 SG SG2012061099A patent/SG183376A1/en unknown
- 2011-02-25 EP EP17167876.6A patent/EP3260135A1/en not_active Withdrawn
- 2011-02-25 WO PCT/AU2011/000206 patent/WO2011103633A1/en not_active Ceased
- 2011-02-25 SG SG10201500976XA patent/SG10201500976XA/en unknown
- 2011-02-25 NZ NZ601890A patent/NZ601890A/en not_active IP Right Cessation
- 2011-02-25 KR KR1020127022892A patent/KR20130036185A/ko not_active Ceased
- 2011-02-25 RU RU2012136724A patent/RU2617399C2/ru not_active IP Right Cessation
- 2011-02-25 EP EP11746760.5A patent/EP2538970A4/en not_active Withdrawn
- 2011-02-25 CN CN201510084917.9A patent/CN104689308B/zh active Active
- 2011-02-25 MX MX2012009730A patent/MX342832B/es active IP Right Grant
-
2012
- 2012-08-17 ZA ZA2012/06204A patent/ZA201206204B/en unknown
-
2018
- 2018-06-26 HK HK18108159.0A patent/HK1248535A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MY162557A (en) | 2017-06-15 |
| US9125853B2 (en) | 2015-09-08 |
| AU2011220335A1 (en) | 2012-09-06 |
| HK1248535A1 (en) | 2018-10-19 |
| WO2011103633A1 (en) | 2011-09-01 |
| MX2012009730A (es) | 2013-02-07 |
| CA2790219C (en) | 2020-06-30 |
| EP2538970A4 (en) | 2013-12-18 |
| TWI583392B (zh) | 2017-05-21 |
| RU2617399C2 (ru) | 2017-04-24 |
| KR20170109685A (ko) | 2017-09-29 |
| KR20130036185A (ko) | 2013-04-11 |
| JP2013520448A (ja) | 2013-06-06 |
| CN104689308B (zh) | 2020-10-20 |
| BR112012021383A2 (pt) | 2017-07-25 |
| JP5977677B2 (ja) | 2016-08-24 |
| TW201138813A (en) | 2011-11-16 |
| RU2012136724A (ru) | 2014-04-10 |
| SG10201500976XA (en) | 2015-04-29 |
| CN102883744A (zh) | 2013-01-16 |
| EP3260135A1 (en) | 2017-12-27 |
| AU2011220335B2 (en) | 2015-04-02 |
| SG183376A1 (en) | 2012-09-27 |
| CN104689308A (zh) | 2015-06-10 |
| MX342832B (es) | 2016-10-14 |
| ZA201206204B (en) | 2013-05-29 |
| US20130129768A1 (en) | 2013-05-23 |
| EP2538970A1 (en) | 2013-01-02 |
| CA2790219A1 (en) | 2011-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ593823A (en) | Compositions and methods for the treatment or the prevention of infections by e. coli | |
| PH12013500952B1 (en) | Oligosaccharide composition for treating acute respiratory tract infections | |
| IN2012DN00624A (enExample) | ||
| MX2011011950A (es) | Composiciones de dexmedetomidina sublinguales y metodos de uso de las mismas. | |
| MX2011011109A (es) | Formulaciones orales de bendamustina. | |
| ZA201304638B (en) | Composition for use in the prevention and /or treatment of skin condition and skin diseases. | |
| BR112013015855A2 (pt) | composto, uso de um composto, métodos de prevenção, tratamento, melhora ou profilaxia de distúrbios fisiológicos ou doenças, e de tratamento ou melhora de indicações cosméticas, e, composição farmacêutica. | |
| NZ593831A (en) | Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces | |
| IN2012DN02805A (enExample) | ||
| MY152279A (en) | Immediate release pharmaceutical compositions comprising oxycodone and naloxone | |
| MX352824B (es) | Uso de levocetirizina y montelukast en el tratamiento de influenza, resfriado común e inflamación. | |
| SG179082A1 (en) | Method for the preparation of an influenza virus | |
| MX2012007166A (es) | Composicion antiviral sinergica y su uso. | |
| EP2538970A4 (en) | TREATMENT OR PREVENTION OF INFECTION | |
| UA107204C2 (uk) | Протигрибкова композиція, що містить грибковий організм pythium oligandrum | |
| MX2011008649A (es) | Vacuna contra el virus del dengue inactivado con un adyuvante libre de aluminio. | |
| MY150931A (en) | Substituted oxazolidinones and their use | |
| MY172788A (en) | Influenza vaccines | |
| MX2012007234A (es) | Nanocristales de monohidrato de calciprotiol. | |
| WO2011091154A3 (en) | Use of human erythrocytes for prevention and treatment of cancer dissemination and growth | |
| WO2013177067A3 (en) | Herbal composition for treatment of gastrointestinal inflammatory diseases and method to prepare and use thereof | |
| TN2012000217A1 (en) | The use of an l3 and/or l5 source as a vaccine or as a diagnostic for a parasitic disease | |
| CA2863829A1 (en) | Oral unit dosage forms and uses of same for the treatment of gaucher disease | |
| WO2010086617A3 (en) | Phosphoantigens for the treatment of burkholderia infections | |
| WO2011028797A3 (en) | Treatment of glaucoma and other retinopathies with gangliosides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 25 FEB 2018 BY LEA Effective date: 20150807 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 FEB 2019 BY CPA GLOBAL(PATRAFEE) AB Effective date: 20180124 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 FEB 2020 BY CPA GLOBAL(PATRAFEE) AB Effective date: 20190214 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 FEB 2021 BY FPA PATENT ATTORNEYS PTY LTD Effective date: 20200128 |
|
| LAPS | Patent lapsed |